SCHEMBL19794521

SCHEMBL19794521

Cc1ccccc1-c1cc(-c2ccccc2[Si](C)(C)C)cc(-c2ccccc2[Si](C)(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.44
▸ RAB9A P51151 5/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ TSHR P16473 5/20 0.42
▸ HPGD P15428 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ TRPA1 O75762 1/20 0.40
▸ CTSD P07339 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ ENPP3 O14638 1/20 0.39
▸ ENPP1 P22413 1/20 0.39
▸ HTR7 P34969 2/20 0.39
▸ LCK P06239 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19897390 0.82 TSHR (0.50) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL19794523 0.82 NPC1 (0.44) NPC1RAB9ASMN1; SMN2TSHRENPP3
SCHEMBL17968220 0.78 MAPK1 (0.48) NPC1RAB9ASMN1; SMN2TSHRHPGD
SCHEMBL20022148 0.78 RAB9A (0.45) NPC1RAB9ASMN1; SMN2TSHRHPGD
SCHEMBL4266240 0.78 CLK4 (0.43) TSHRALDH1A1TRPA1CTSDBACE1
SCHEMBL5085077 0.76 ALDH1A1 (0.42) NPC1RAB9ASMN1; SMN2TSHRHPGD
SCHEMBL20022131 0.76 ENPP3 (0.49) NPC1RAB9ASMN1; SMN2TSHRHPGD
SCHEMBL20022100 0.76 ENPP3 (0.49) NPC1RAB9ASMN1; SMN2TSHRHPGD
SCHEMBL31097920 0.75 SMN1; SMN2 (0.37) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL3361069 0.74 HTR7 (0.43) NPC1RAB9ASMN1; SMN2CASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 NPC1 2761/4885RAB9A 1433/4885SMN1; SMN2 4144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback